Skip to content

Perfluorohexyloctane

Semifluorinated Alkane

Also known as: F6H8, miebo, NOV03, perfluorhexyloctane

OnpFDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Perfluorohexyloctane is an onp drug in the Semifluorinated Alkane class catalogued in DrugCentral. It was first approved by the FDA in 2023. Recorded indications include Dry eye disease.

  • Approval status: onp (first approved 2023 by the FDA).
  • Drug class: Semifluorinated Alkane.
  • Indications: Dry eye disease.
  • Molecular formula: C14H17F13; molecular weight 432.27 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Dry eye disease

Mechanism & targets

Established pharmacologic classSemifluorinated Alkane

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2023-05-18FDA—BAUSCH AND LOMB INC

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Eye irritation178.0
Eye pain97.6
Ocular hyperaemia94.7
Vision blurred84.3

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Perfluorohexyloctane is on its molecule page.

Molecular formulaC14H17F13
Molecular weight432.27 g/mol
CAS number133331-77-8
InChIKeyWRYIIOKOQSICTB-UHFFFAOYSA-N
PubChem CID10477896
CCCCCCCCC(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Perfluorohexyloctane used for?

DrugCentral lists the following indications for Perfluorohexyloctane: Dry eye disease.

When was Perfluorohexyloctane first approved?

Perfluorohexyloctane was first approved by the FDA in 2023.

What drug class does Perfluorohexyloctane belong to?

Perfluorohexyloctane is in the Semifluorinated Alkane class.

What is the chemical formula of Perfluorohexyloctane?

Perfluorohexyloctane has the molecular formula C14H17F13 and a molecular weight of 432.27 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusONP
First approval2023-05-18
AgencyFDA
Targets0
Indications1
FormulaC14H17F13
DrugCentral ID5730
Interactive profile